In this conversation, Jim Martin, CEO of Cocrystal Pharma, discusses his journey from a career in finance to leading a biotechnology company focused on developing antiviral treatments. He explains the unique challenges of the biotech industry, particularly the importance of efficiency and cost management in drug development. He also shares insights into the FDA approval process and the strategic decisions involved in bringing new therapeutics to market.
